Fig. 15From: Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s disease4-Phenylpiperazine substituted coumarin derivatives C9 and C10Back to article page